Griwaditi

Cervical cancer kills over 3,00,000 women every year – a tragedy because cervical cancer takes 20 years to develop, and can be treated for less than $28 in less than 40 minutes if caught in the first 5 years. The current diagnostic techniques are inaccessible with precision, or are time consuming, expensive, and require highly equipped laboratories which are not available in developing countries, where the disease is endemic. As a result, 80% of the Cervical Cancer cases are diagnosed at stage-III.  

Griwaditi is the first automated, non-invasive and easily accessible screening tool for Cervical Cancer, which comprises of a point-of-care portable imaging device to produce high resolution magnified images of the cervix, with a unique cervical cancer lesion detection algorithm running on mobile phone to quickly screen cervical cancer. Fitted for speculums and operated with any smartphone, the Griwaditi system offers low-cost cervical cancer screening for women in low and middle-income countries. Besides, a remote diagnostic application facilitates sharing of images across to gain consultation from experts right-away via a cloud-based tele-oncology platform.